Publications 2002

1. Pfeilschifter J, Beck KF, Eberhardt W, and Huwiler A. Changing gears in the course of glomerulonephritis by shifting superoxide to nitric oxide-dominated chemistry: a working hypothesis. Kidney Int. 61, 809-815, 2002

2. Pautz A, Franzen R, Dorsch S, Böddingshaus B, Briner VA, Pfeilschifter J, and Huwiler A. Cell-specific cross-communication between nitric oxide and superoxide determines ceramide formation and apoptosis in renal glomerular cells. Kidney Int. 61, 790-796, 2002

3. Frank S, Kämpfer H, Wetzler C, and Pfeilschifter J. Nitric oxide drives skin repair: novel functions of an established mediator. Kidney Int. 61, 882-888, 2002

4. Manderscheid M, Pereda-Fernandez C, and Pfeilschifter J. Cyclic AMP increases rat inhibitor of Apoptosis Protein (RIAP1) mRNA in Renal Mesangial Cells. Kidney Int. 61, 797-803, 2002

5. Stefan Frank and Heiko Kämpfer. Excisional Wound Healing: An Experimental Approach in "Wound healing: Methods and Protocols." Humana Press In., Totowa, USA, 3-15, 2002

6. Loew D and Kaszkin M. Biovailabilityof harpagoside and its relation to in-vitro/in-vivo conformity of cysteinyl-leukotriene biosynthesis. Clin. Pharmacol. Ther - Vol. 71, Nr 1, Jan 2002

7. Pfeilschifter J. Nitric oxide triggers the expression of proinflammatory and protective gene
products in mesangial cells and the inflamed glomerulus. Nephrol. Dial. Transplant 17, 347-348, 2002

8. Eberhardt W, Beck KF, and Pfeilschifter J. Cytokine-induced expression of tPA is differentially modulated by NO and ROS in rat mesangial cells. Kidney Int. 61, 20-30, 2002

9. Dieter P, Kolada A, Kamionka S, Schadow A, and Kaszkin M. LPS-induced release of arachidonic acid and prostaglandins in liver macrophages: Involvement of group IV cytosolic phospholipase A2, but not by group V and group IIA secretory phosholipase A2. Cell Signal. 14, 199-204, 2002

10. Stallmeyer B, Anhold M, Wetzler C, Kahlina K, Pfeilschifter J, and Frank S. Regulation of eNOS in normal and diabetes-impaired skin repair: implications for tissue regeneration. Nitric Oxide: Biology and Chemistry 6, 168-177, 2002

11. Scholz-Pedretti K, Gans A, Beck KF, Pfeilschifter J, and Kaszkin M. Potentiation of TNFa-stimulated group IIA phospolipase A2 expression by PPARa activators in rat mesangial cells. J. Am. Soc. Nephrol. 13, 611-620, 2002

12. Beck GCH, Yard BA, Schulte J, Oberacker R, van Ackern K, van der Woude FJ, Krimsky M, Kaszkin M, and Yedgar S. Inhibition of LPS-induced chemokine production in human lung endothelial cells by lipid conjugates anchored to the membrane. Brit J of Pharm 135, 1665-1674, 2002

13. Urbich C, Reissner A, Chavakis E, Dernbach E, Haendeler J, Fleming I, Zeiher A, Kaszkin M, and Dimmeler S. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB J. 16(7), 706-708, 2002

14. Schwarz M, Wahl M, Resch K, and Radeke HH. IFNg induces functional chemokine receptor expression in human mesangial cells. Clin Exp Immunol 2002, 128:285-294, 2002

15. Pfeilschifter J and Huwiler A. Inflammation. In Encyclopedic Reference of Molecular Pharmacology, Offermanns S, Rosenthal W (eds), Springer, Heidelberg 2002

16. Cattell V and Pfeilschifter J. Nitric oxide and renal inflammation. Kidney Int. 61, 781-782, 2002

17. Rodriguez I, Kaszkin M, Holloschi A, Kabsch K, Marques MM, Mao X, and Alonso A. Hyperosmotic stress induces phosphorylation of cytosolic phospholipase A2 in HaCaT cells by an epidermal growth factor receptor-mediated process. Cell Signal. 14, 839-848, 2002

18. Loew D und Kaszkin M. Äquivalenz von Extrakten: Möglichkeiten und Forschungsbedarf. In: Phytopharmaka VII – Forschung und klinische Anwendung. Schulz, Rietbrock, Roots, Loew eds.,Steinkopff Verlag, Darmstadt, Vol. 7, Kapitel 20, 2002

19. Rölz W, Xin C, Ren S, Pfeilschifter J, and Huwiler A. Interleukin-1 inhibits angiotensin II stimulated protein kinase B pathway in renal mesangial cells via the inducible nitric oxide synthase. Eur. J. Pharmacol. 10, 195-203, 2002

20. Eberhardt W, Schulze M, Engels C, Klasmeier E, and Pfeilschifter J. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of NF-kB and Ets transcription factors. Mol. Endocrinol. 16, 1752-1766, 2002

21. Huwiler A, Rölz W, Dorsch S, Ren S, and Pfeilschifter J. Extracellular ATP and UTP activate the protein kinase B/Akt cascade via the P2Y2 purinoceptor in renal mesangial cells. Br. J. Pharmacol 136, 520-529, 2002

22. Schacke W, Beck KF, Pfeilschifter J, Koch F, and Hattenbach LO. Modulation of tissue
plasminogen activator and plasminoge activator inhibitor-1 by transforming growth factor-b in human retinal glial cells. Invest Ophthalmol Vis Sci, 43, 2799-2805, 2002

23. Hellmuth M, Wetzler C, Nold M, Chang J-H, Frank S, Pfeilschifter J, and Mühl H. Expression of Interleukin-8, Heme Oxygenase-1, and Vascular Endothelial Growth Factor in DLD-1 Colon Carcinoma Cells Exposed to Pyrrolidine Dithiocarbamate. Carcinogenesis 8, 1273-1279, 2002

24. Eberhardt W, Engels C, Müller R, and Pfeilschifter J. Mechanism of dexamethasone-mediated inhibition of cAMP-induced tPA expression in rat mesangial cells. Kidney Int. 162, 809-821, 2002

25. Janssen U, Sowa E, Marchand P, Floege J, Phillips AO, and Radeke HH. Differential Expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells. Nephron 92(4), 797-806, 2002

26. Radeke HH, Janssen-Graalfs I, Sowa EN, Löscher F, Schmidt RE, and Gessner J. Opposite regulation of type II and II receptors for immunoglobulin G in mouse glomerula mesangial cells. J Biol Chem 277(30), 27535-27544, 2002

27. Radeke HH, Tschernig T, Karulin A, Schumm G, Emancipator SN, Resch K, and Tary-Lehmann M. CD4+ T cells recognizing specific antigen deposited in glomeruli cause glomerulonephritis-like kidney injury. Clinical Immunology 104(2), 161-173, 2002

28. Eberhardt W, Akool EL-S, Rebhan J, Frank S, Beck KF, Franzen R, Hamada F MA, and Pfeilschifter J. Inhibition of cytokine-induced MMP-9 expression by PPARa agonists is indirect and is due to NO-mediated reduction of mRNA stability. J Biol Chem. 36, 33518-33528, 2002

29. Turchanowa L, Shvetsov AS, Demin AV, Khomutov AR, Wallace HM, Stein J, and Milovic V. Insufficiently charged isoteric analogue of spermine: interaction with polyamine uptake, and effect on Caco-2 cell growth. Biochem Pharmacol 64, 649-655, 2002

30. Li H, Junk P, Huwiler A, Burkhardt C, Strauch S, Wallerath T, Pfeilschifter J, and Förstermann U. Dual Effect of Ceramide on Human Endothelial Cells. Circulation 106, 2250-2256, 2002

31. Loew D and Kaszkin M. Approaching the problem of bioequivalence of Herbal Medicinal Products. Phytother.Res. 16, 705-711, 2002

32. Franzen R, Fabbro D, Aschrafi A, Pfeilschifter J, and Huwiler A. Nitric oxide induces degradation of the neutral ceramidase in rat renal mesangial cells and is counterregulated by protein kinase C. J. Biol. Chem 277, 46184-46190, 2002

33. Shabahang S, Huwiler A, and Pfeilschifter J. Identification of the LIM kinase-1 as a cermaide-regulated gene in renal mesangial cells. Biochem. Biophys. Res. Commun. 298, 408-413, 2002

34. Schnorr O, Bruch-Gerharz D, Suschek C, Beck KF, Pfeilschifter J, Ruzicka T, and Kolb-Bachofen V. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. American Journal of Pathology 2002

35. Uhlenbrock K, Gassenhuber H, and Kostenis E. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cell Signal 14, 941-953, 2002

36. Franzen R, Pfeilschifter J, and Huwiler A. Nitric oxide induces neutral ceramidase degradation by the ubiquitin/proteasome complex in renal mesangial cell cultures. FEBS Letters 532, 441-444, 2002

37. Feng WH, Westphal E, Mauser A, Raab-Traub N, Gulley ML, Busson P, and Kenney SC. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors. J Virol. 76, 10951-10959, 2002

38. Westphal EM and Melchner Hv H. Gene therapy approaches for the selective killing of cancer cells. Curr Pharm Des. 8, 1683-1694, 2002 Review

39. Loew D and Kaszkin M. Experimentell- und klinisch-pharmakologische Modelle zum Nachweis der analgetischen und antiphlogistischen Wirkungen von Teufelskralle. Ärztezeitschrift für Naturheilverfahren 43 (9), 576-585, 2002

40. Bauer M, Suppmann S, Meyer M, Hesslinger C, Gasser T, Widmer HR, and Ueffing M. Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones. J. Neurochem. 82, 1300-1310, 2002

41. Münchow S, Ferring D, Kahlina K, and Jansen RP. Characterization of Candida albicans ASH1 in Saccharomyces cerevisiae. Curr Genet 41, 73-81, 2002


Auf der rechten Seite finden Sie Links zu Publikationen aus den Jahren 2013-2015.

Zur Gesamtübersicht bitte folgenden Link verwenden: Zu den Publikationen
zu Publikationen 2017
zu Publikationen 2016
zu Publikationen 2015
Sekretariat Prof. Dr. Josef Pfeilschifter

Telefon: +49-69-6301-6951
Fax: +49-69-6301-7942/ -7420
Pub Med Online